Cloning, Expression and Activity of Modified Recombinant Human Endostatin with Her2 Nanobody Fusion Protein

Peng GU,Jia-huang LI,Gen-xing XU,Zi-chun HUA

DOI: https://doi.org/10.19526/j.cnki.1005-8915.20170302

2017-01-01

Abstract:Her2 is the best target for detection and treatment of breast cancer,and over activation in 26％ of breast cancer patients.Because of its small molecular weight,high stability,good solubility,being easy to express,low immunogenicity,and so on,nanobody (VHH) has become a new star in the development of detection reagents.The aim of this study was to develop a kind of bifunctional protein targeting to breast cancer,and to explore its inhibitory effect on breast cancer cells.The prokaryotic expression plasmid of fusion protein of the Her2 nanobody targeting to breast cancer and the modified human endostatin targeting to vascular endothelial cell was constructed by molecular biology method,and a large number of expression vectors were obtained.CCK8 assay was used to detect the inhibitory effect of soluble target protein on the growth of breast cancer,and the specificity and internalization of soluble target protein were detected by immunofluorescence assay.Using overlapping PCR successfully constructed modified endostatin mutationgene [endo (m)],and then by restriction enzyme digestion method with the Dim gene was cloned into the prokaryotic expression vector pET28a,successfully constructed fusion expression plasmid pET28a-Dim-endo (m).The fusion protein Dim-endo (m) was expressed in the form of inclusion body,and the inclusion body refolding method was used to obtain a large amount of soluble target protein.It was showed that the fusion protein can bind to Her2 positive breast cancer SKBR3 cells by cell immunofluorescence,and can inhibit the proliferation of tumor cells.The fusion protein of Her2 nanobody with modified endostatinprokaryotic expression vector pET28a-Dim-endo(m) was successfully constructed and expressed.It can bind to Her2 receptors in breast cancer cells,and can enter the cell by the transcriptional-activator-protein role.It also can inhibit tumor cell growth and may be used for breast cancer detection reagent for follow-up research.